(Q44708185)

5 December 2017

title

Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil (English)

1 reference

5 December 2017

1 reference

C Miroux

1

1 reference

5 December 2017

O Morales

2

1 reference

5 December 2017

L Ouaguia

3

1 reference

5 December 2017

L Aoudjehane

4

1 reference

5 December 2017

E Boleslawski

5

1 reference

5 December 2017

V Pancré

6

1 reference

5 December 2017

Y de Launoit

7

1 reference

5 December 2017

Y Calmus

8

1 reference

5 December 2017

F Conti

9

1 reference

5 December 2017

N Delhem

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

Transplantation Proceedings

5 December 2017

published in

1 reference

5 December 2017

volume

44

1 reference

5 December 2017

issue

9

1 reference

5 December 2017

page(s)

2834-2839

1 reference

Regulatory T cells and mechanisms of immune system control

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

A function for interleukin 2 in Foxp3-expressing regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Low circulating regulatory T-cell levels after acute rejection in liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Hepatitis B and hepatitis C viruses in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Outcome of posttransplantation hepatitis C virus disease--is it the host, the virus, or how we modify the host and/or the virus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Natural history of hepatitis C following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Inhibitory effects of cyclosporine on human regulatory T cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Dexamethasone upregulates FOXP3 expression without increasing regulatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

Influence of short-term glucocorticoid therapy on regulatory T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.09.091

10.1016/J.TRANSPROCEED.2012.09.091

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference